TABLE 3.

In vitro susceptibilities of Cryptococcus neoformans to voriconazole, posaconazole, and ravuconazolea

Antifungal agentNo. of isolates testedCumulative % inhibited at MIC (μg/ml) of:
0.0070.0150.030.060.120.250.51248
Voriconazole1,8002826628997999999100
Posaconazole1,64600.421262829799100
Ravuconazole1,0482836618295989999100
  • a Broth microdilution testing according to NCCLS M27-A2 (30).